Dec 29 (Reuters) - Nova Mentis Life Science Corp NOVA.CD :
* NOVA MENTIS LIFE SCIENCE CORP - CO SAYS HAS ADDED TWO ADDITIONAL PSYCHEDELIC COMPOUNDS TO ITS DRUG PORTFOLIO
* NOVA MENTIS - AS PER AGREEMENTS, CO HAS OWNERSHIP OF API DMF WHICH WILL BE USED FOR REGULATORY SUBMISSION PRIOR TO COMMENCING HUMAN CLINICAL TRIALS
* NOVA MENTIS - CO HAS CONTRACTED WITH ITS U.S. PARTNER TO BEGIN MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS, BAEOCYSTIN AND AERUGINASCIN